연구성과로 돌아가기
2020 연구성과별 연구자 정보 (961 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study | Jang, Jeong Won | Jang, JW | 3 | Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea | LOS-2890-2024 | Jang, Jeong | jkwoh@ionisph.com; | |||
| Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study | Yoon, Jung-Hwan | Yoon, JH | 4 | Seoul Natl Univ Hosp, Seoul, South Korea | J-5563-2012 | Yoon, Jung | jkwoh@ionisph.com; | |||
| Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study | Kweon, Young Oh | Kweon, YO | 5 | Kyungpook Natl Univ Hosp, Daegu, South Korea | jkwoh@ionisph.com; | |||||
| Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study | Park, Sung-Jae | Park, SJ | 6 | Inje Univ, Busan Paik Hosp, Busan, South Korea | jkwoh@ionisph.com; | |||||
| Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study | Bennett, C. Frank | Bennett, CF | 7 | Ionis Pharmaceut Inc, Carlsbad, CA USA | jkwoh@ionisph.com; | |||||
| Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study | Kwoh, T. Jesse | Kwoh, TJ | 8 | Ionis Pharmaceut Inc, Carlsbad, CA USA | jkwoh@ionisph.com; | |||||
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Kim, Seung Up | Kim, SU | 1 | Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea | AAA-4643-2022 | KIM, JEONGSEON | 0000-0002-9658-8050 | Kim, Seung Up | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Kim, Seung Up | Kim, SU | 1 | Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea | AAA-4643-2022 | KIM, JEONGSEON | 0000-0002-9658-8050 | Kim, Seung Up | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Kim, Seung Up | Kim, SU | 1 | Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea | AAA-4643-2022 | KIM, JEONGSEON | 0000-0002-9658-8050 | Kim, Seung Up | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Seo, Yeon Seok | Seo, YS | 2 | Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |||||
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Lee, Han Ah | Lee, HA | 3 | Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |||||
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Kim, Mi Na | Kim, MN | 4 | CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |||||
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Lee, Eun Ju | Lee, EJ | 5 | Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Biostat Collaborat Unit, Seoul, South Korea | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |||||
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Shin, Hye Jung | Shin, HJ | 6 | Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Biostat Collaborat Unit, Seoul, South Korea | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |||||
| Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study | Lee, Yu Rim | Lee, YR | 7 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea | ITU-1407-2023 | Lee, YuRim | beomkkim@yuhs.ac;psyoung0419@gmail.com; |
페이지 이동: